Orbcomm announced Wednesday that it has executed an agreement with VeriChip, a subsidiary of Applied Digital, to be its provider of satellite and telecommunication services for applications to be developed for use with the world’s first implantable radio frequency identification (RFID) microchip, also called VeriChip.
Under the terms of the agreement, the companies will also work together to develop and market new military, security, and healthcare applications for use in the United States and around the world.
VeriChip Corporation is a wholly owned subsidiary of Applied Digital. The VeriChip product is a subdermal RFID microtransponder that can be used in a variety of security, financial, emergency identification and healthcare applications.
About the size of a grain of rice, each VeriChip Device contains a unique verification number that is captured by briefly passing a proprietary scanner over the VeriChip.
In October 2004, the U.S. Food and Drug Administration (FDA) cleared VeriChip for medical applications in the United States. VeriChip is not a FDA-regulated device with regards to its security, financial, personal identification/safety applications.
“Orbcomm’s relationship with VeriChip provides yet another new and important industry that will use the Orbcomm satellite system and its ground infrastructure network to transmit messages globally,” Jerry Eisenberg, CEO of Orbcomm, said.
